Patent details

EP2897943 Title: CRYSTALLINE FORM OF VORTIOXETINE HYDROBROMIDE

Basic Information

Publication number:
EP2897943
PCT Application Number:
EP2013069401
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137628723
PCT Publication Number:
WO2014044721
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORM OF VORTIOXETINE HYDROBROMIDE
French Title of Invention:
FORME CRISTALLINE DE BROMHYDRATE DE VORTIOXÉTINE
German Title of Invention:
KRISTALLINE FORM VON VORTIOXETINHYDROBROMID
SPC Number:

Dates

Filing date:
18/09/2013
Grant date:
24/04/2019
EP Publication Date:
29/07/2015
PCT Publication Date:
27/03/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/04/2019
EP B1 Publication Date:
24/04/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/09/2019
Expiration date:
18/09/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/05/2018
 
 

Name:
Sandoz AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
ENDERS, Michael
Address:
Austria (AT)

2

Name:
HOTTER, Andreas
Address:
Austria (AT)

3

Name:
GRIESSER, Ulrich
Address:
Austria (AT)

Priority

Priority Number:
12185103
Priority Date:
19/09/2012
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/495; A61P 25/00; C07D 295/096;

Publication

European Patent Bulletin

Issue number:
201917
Publication date:
24/04/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages